Literature DB >> 1454823

Differential effects of Bcl-2 on T and B cells in transgenic mice.

M Katsumata1, R M Siegel, D C Louie, T Miyashita, Y Tsujimoto, P C Nowell, M I Greene, J C Reed.   

Abstract

We have produced bcl-2 transgenic mice by using a construct which mimics the t(14;18) translocation in human follicular lymphomas. Although lymphoid tissues from all transgenic mice contained high levels of human Bcl-2 protein, transgene expression was differentially regulated within the B- and T-cell compartments of lines derived from various founder mice. We have characterized the phenotypes of two lines of bcl-2 transgenic mice (line 2 and line 6) in which bcl-2 transgene expression was restricted primarily to the T- or B-cell lineages, respectively. Analysis of line 6 lymphocytes revealed a polyclonal expansion of B cells, and these B cells exhibited prolonged survival in vitro. In line 2 mice, numbers of T cells in the peripheral lymphoid tissues were more moderately elevated despite enhanced T-cell survival in vitro. Line 2 transgenic mice also showed significantly increased proportions of thymocytes with a mature phenotype. Taken together, these findings suggest different roles for bcl-2 in the in vivo regulation of B- and T-cell development and homeostasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454823      PMCID: PMC50553          DOI: 10.1073/pnas.89.23.11376

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

Authors:  S Henderson; M Rowe; C Gregory; D Croom-Carter; F Wang; R Longnecker; E Kieff; A Rickinson
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

2.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.

Authors:  A Strasser; A W Harris; S Cory
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

3.  Chromosome abnormalities in poorly differentiated lymphocytic lymphoma.

Authors:  S Fukuhara; J D Rowley; D Variakojis; H M Golomb
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

4.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

Authors:  D Hockenbery; G Nuñez; C Milliman; R D Schreiber; S J Korsmeyer
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

5.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

6.  DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene.

Authors:  Y Tsujimoto; M M Bashir; I Givol; J Cossman; E Jaffe; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

7.  Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.

Authors:  Y J Liu; D Y Mason; G D Johnson; S Abbot; C D Gregory; D L Hardie; J Gordon; I C MacLennan
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

8.  The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

Authors:  Y Tsujimoto; J Gorham; J Cossman; E Jaffe; C M Croce
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

9.  Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice.

Authors:  R M Siegel; M Katsumata; T Miyashita; D C Louie; M I Greene; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  The kinetics of T cell antigen receptor expression by subgroups of CD4+8+ thymocytes: delineation of CD4+8+3(2+) thymocytes as post-selection intermediates leading to mature T cells.

Authors:  K Shortman; D Vremec; M Egerton
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more
  43 in total

1.  Ian4 is required for mitochondrial integrity and T cell survival.

Authors:  Malini Pandarpurkar; Leanne Wilson-Fritch; Silvia Corvera; Helle Markholst; Lars Hornum; Dale L Greiner; John P Mordes; Aldo A Rossini; Rita Bortell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

2.  BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

Authors:  Jun Wei; John L Stebbins; Shinichi Kitada; Rupesh Dash; William Placzek; Michele F Rega; Bainan Wu; Jason Cellitti; Dayong Zhai; Li Yang; Russell Dahl; Paul B Fisher; John C Reed; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

Review 3.  Molecular basis of CLL.

Authors:  Yuri Pekarsky; Nicola Zanesi; Carlo M Croce
Journal:  Semin Cancer Biol       Date:  2010-09-21       Impact factor: 15.707

4.  Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

Authors:  Jun Wei; Shinichi Kitada; John L Stebbins; William Placzek; Dayong Zhai; Bainan Wu; Michele F Rega; Ziming Zhang; Jason Cellitti; Li Yang; Russell Dahl; John C Reed; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2010-10-29       Impact factor: 7.446

5.  Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1.

Authors:  G A Blobel; S H Orkin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins.

Authors:  Jun Wei; Shinichi Kitada; Michele F Rega; Aras Emdadi; Hongbin Yuan; Jason Cellitti; John L Stebbins; Dayong Zhai; Jiazhi Sun; Li Yang; Russell Dahl; Ziming Zhang; Bainan Wu; Si Wang; Tyler A Reed; Hong-Gang Wang; Nicholas Lawrence; Said Sebti; John C Reed; Maurizio Pellecchia
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

7.  Bcl-2 overexpression enhances tumor-specific T-cell survival.

Authors:  Jehad Charo; Steven E Finkelstein; Navrose Grewal; Nicholas P Restifo; Paul F Robbins; Steven A Rosenberg
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

8.  Apoptosis and Bcl-2 expression in cultured murine splenic T cells.

Authors:  H E Broome; C M Dargan; E F Bessent; S Krajewski; J C Reed
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

9.  Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).

Authors:  Shinichi Kitada; Christina L Kress; Maryla Krajewska; Lee Jia; Maurizio Pellecchia; John C Reed
Journal:  Blood       Date:  2008-01-17       Impact factor: 22.113

10.  Binding of DNA oligonucleotides to sequences in the promoter of the human bc1-2 gene.

Authors:  W M Olivas; L J Maher
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.